The announcement itself is little more than a headline: SGX and MSCI have a new licensing agreement, per the Reuters item run on TradingView on July 23, 2026, with no pricing, product scope, or contract length given. That opacity is the story for anyone tracking the index-licensing business, where benchmark providers like MSCI extract recurring fees from exchanges that build derivatives and ETF franchises on top of their IP. Index licensing has become one of the most durable, high-margin revenue lines in market data precisely because deals like this rarely come with disclosed economics — investors and rival venues are left to infer scale from downstream product listings rather than contract terms.
A licensing headline with no numbers attached is a reminder that the index business runs on terms nobody outside the room ever sees.
Worth watching for follow-up filings or product launch notices from SGX naming specific MSCI benchmarks, which would be the first real signal of what this agreement actually covers.
Singapore Exchange Announces New Licensing Agreement With MSCI
